Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionStifel Financial Corp
Latest Disclosed Ownership13,877 shares
Latest Disclosed Value $ 1,828,159
Stifel Financial Corp reports 21.67% increase in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 12, 2026 - Stifel Financial Corp filed a 13F-HR form disclosing ownership of 13,877 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $1,828,159 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 11,405 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 21.67% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,877 2,472 21.67 1,828 13.05 0.0004
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,405 -2,592 -18.52 1,618 -17.67 0.0015
2025-11-12 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,997 -2,918 -17.25 1,965 -7.62 0.0018
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,915 -1,281 -7.04 2,126 5.67 0.0021
2025-05-14 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,196 -4,480 -19.76 2,012 -34.99 0.0021
2025-02-13 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 22,676 4,425 24.25 3,095 47.24 0.0032
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,251 84 0.46 2,103 -15.95 0.0022
2024-08-13 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,167 -951 -4.97 2,501 -5.12 0.0028
2024-05-14 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,118 749 4.08 2,637 8.93 0.0030
2024-02-12 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,369 -425 -2.26 2,420 14.47 0.0030
2023-11-13 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,794 3,802 25.36 2,114 49.61 0.0030
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 14,992 -587 -3.77 1,414 -10.34 0.0019
2023-05-12 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,579 -142 -0.90 1,577 -16.04 0.0023
2023-02-13 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,721 -1,746 -10.00 1,878 1.13 0.0028
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,467 -1,503 -7.92 1,856 0.38 0.0030
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,970 -5,259 -21.71 1,849 -18.58 0.0029
2022-05-13 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 24,229 -2,326 -8.76 2,271 0.40 0.0031
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 26,555 -6,619 -19.95 2,262 -28.89 0.0030
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 33,174 -2,843 -7.89 3,181 -9.24 0.0047
2021-08-13 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 36,017 4,156 13.04 3,505 13.14 0.0052
2021-05-14 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 31,861 896 2.89 3,098 4.38 0.0051
2021-02-12 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 30,965 2,564 9.03 2,968 8.68 0.0053
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 28,401 5,104 21.91 2,731 -3.91 0.0056
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 23,297 3,610 18.34 2,842 65.71 0.0065
2020-05-14 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,687 -2,914 -12.89 1,715 -29.39 0.0047
2020-02-13 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 22,601 7,260 47.32 2,429 74.12 0.0051
2019-11-19 2019-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 15,341 7,793 103.25 1,395 116.95 0.0036
2019-11-13 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,325 7,777 1,394 781.4069
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,548 3,715 96.92 643 86.92 0.0017
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,833 3,833 344 0.0010
2019-02-13 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -3,102 -100.00 0 -100.00
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,102 3,102 383 0.0011
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -4,029 -100.00 0 -100.00
2017-11-13 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,029 4,029 246 0.0009
2016-05-16 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -4,104 -100.00 0 -100.00
2016-03-21 2015-12-31 13F/A-2 NEUROCRINE BIOSCIENCES COM 64125C109 4,104 4,104 232 0.0012
2016-02-26 2015-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 4,104 0 232 0.0012
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,104 232 0.0011
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.